L Jacob1, K Kostev2. 1. Faculty of Medicine, University of Paris 5, Paris, France. 2. Department of Epidemiology, IMS Health, Darmstädter Landstraße 108, 60598, Frankfurt am Main, Germany. kkostev@de.imshealth.com.
Abstract
Two thousand eight hundred ninety-four children and adolescents treated by 243 pediatricians were analyzed. Patients receiving attention deficit hyperactivity disorder (ADHD) medications were at a lower risk of fractures than patients without ADHD medications. The strongest impact was in the age group of 6-9 years. Finally, there was a significant association between therapy duration and fracture risk. INTRODUCTION: The aim of this study was to analyze the impact of ADHD therapy on fracture risk in children treated by German pediatricians. METHODS: Children and adolescents initially diagnosed with ADHD and fractures between 2010 and 2015 were identified by 243 pediatricians. In this nested case-control study, each ADHD case with a fracture was matched (1:1) to an ADHD control without a fracture for age, gender, index year, and physician. In total, 2894 individuals were available for analysis. The main outcome of the study was the risk of fracture as a function of ADHD therapy. Multivariate logistic regression models were created to determine the effect of ADHD therapy on the risk of fracture in the entire population and in three age-specific subgroups. RESULTS: Patients receiving ADHD medications were at a lower risk of fracture than patients without ADHD medications (OR = 0.61). The impact of ADHD therapy on the risk of fracture was stronger in the age group of 6-9 years (OR = 0.41) than in the age groups of 10-13 years (OR = 0.68) and 14-17 years (OR = 0.74). Finally, a significant correlation was found between therapy duration and fracture risk (OR = 0.71 per month). CONCLUSION: ADHD therapy was associated with a decrease in the risk of fracture in children and adolescents treated by German pediatricians.
Two thousand eight hundred ninety-four children and adolescents treated by 243 pediatricians were analyzed. Patients receiving attention deficit hyperactivity disorder (ADHD) medications were at a lower risk of fractures than patients without ADHD medications. The strongest impact was in the age group of 6-9 years. Finally, there was a significant association between therapy duration and fracture risk. INTRODUCTION: The aim of this study was to analyze the impact of ADHD therapy on fracture risk in children treated by German pediatricians. METHODS:Children and adolescents initially diagnosed with ADHD and fractures between 2010 and 2015 were identified by 243 pediatricians. In this nested case-control study, each ADHD case with a fracture was matched (1:1) to an ADHD control without a fracture for age, gender, index year, and physician. In total, 2894 individuals were available for analysis. The main outcome of the study was the risk of fracture as a function of ADHD therapy. Multivariate logistic regression models were created to determine the effect of ADHD therapy on the risk of fracture in the entire population and in three age-specific subgroups. RESULTS:Patients receiving ADHD medications were at a lower risk of fracture than patients without ADHD medications (OR = 0.61). The impact of ADHD therapy on the risk of fracture was stronger in the age group of 6-9 years (OR = 0.41) than in the age groups of 10-13 years (OR = 0.68) and 14-17 years (OR = 0.74). Finally, a significant correlation was found between therapy duration and fracture risk (OR = 0.71 per month). CONCLUSION:ADHD therapy was associated with a decrease in the risk of fracture in children and adolescents treated by German pediatricians.
Entities:
Keywords:
Attention deficit hyperactivity disorder; Children and adolescents; Fracture risk; Germany
Authors: Salvatore Mannuzza; Rachel G Klein; Nhan L Truong; John L Moulton; Erica R Roizen; Kathryn H Howell; Francisco X Castellanos Journal: Am J Psychiatry Date: 2008-04-01 Impact factor: 18.112
Authors: Holly E Erskine; Alize J Ferrari; Guilherme V Polanczyk; Terrie E Moffitt; Christopher J L Murray; Theo Vos; Harvey A Whiteford; James G Scott Journal: J Child Psychol Psychiatry Date: 2014-01-22 Impact factor: 8.982
Authors: Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson Journal: Biol Psychiatry Date: 2019-04-17 Impact factor: 13.382